Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous coronary intervention: current perspective.

T Hinohara1

  • 1Sequoia Hospital, Redwood City, CA, USA.

The Keio Journal of Medicine
|October 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The StarClose Vascular Closure System: interventional results from the CLIP study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2006
Same author

The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2006
Same author

Replication in restenotic atherectomy tissue.

Atherosclerosis·2000
Same author

Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials.

The American journal of cardiology·2000
Same author

Effects of adjunctive balloon angioplasty after intravascular ultrasound-guided optimal directional coronary atherectomy: the result of Adjunctive Balloon Angioplasty After Coronary Atherectomy Study (ABACAS).

Journal of the American College of Cardiology·1999
Same author

[A case of leiomyosarcoma of the jejunum with postoperative hepatic encephalopathy].

Gan to kagaku ryoho. Cancer & chemotherapy·1998
Same journal

Transcript of the Commemorative Lecture by Dr. Akiko Iwasaki (30th Keio Medical Science Prize Award Ceremony).

The Keio journal of medicine·2026
Same journal

Association of Loneliness and Health Literacy with Overuse of Over-the-counter Drugs in Patients with COVID-19 in Japan.

The Keio journal of medicine·2026
Same journal

Ligustilide Attenuates Neuroinflammation and Fibrosis in an Aluminum Chloride-induced Rat Model of Alzheimer's Disease via mTOR/STAT3 Signaling Inhibition.

The Keio journal of medicine·2026
Same journal

Community Pharmacists' Attitudes and Experiences Regarding the Promotion of Vaccinations in Japan.

The Keio journal of medicine·2026
Same journal

Identifying High-Cost RSV Hospitalizations at a Secondary Hospital in Japan.

The Keio journal of medicine·2026
Same journal

Comparison of Clinical Development of Digital Therapeutics among Japan, the Unites States, and Germany.

The Keio journal of medicine·2025
See all related articles

Percutaneous coronary intervention (PCI) has evolved significantly over 20 years, overcoming initial limitations like restenosis with new devices and drugs. Ongoing advancements promise to further expand PCI applications for coronary artery disease treatment.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Disease Treatment
  • Medical Device Technology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) introduced over two decades ago revolutionized coronary artery disease treatment.
  • Early PTCA success was limited by acute occlusive complications and restenosis.
  • Significant improvements in PCI outcomes were observed during the first decade of its use.

Purpose of the Study:

  • To review the evolution of percutaneous coronary intervention (PCI) over the past 20 years.
  • To highlight advancements in technology and pharmacotherapy that have improved PCI outcomes.
  • To discuss future directions and potential applications of PCI.

Main Methods:

  • Review of advancements in interventional cardiology procedures and technologies.

Related Experiment Videos

  • Examination of the impact of new devices like stents and atherectomy tools.
  • Analysis of the role of pharmacologic agents, such as glycoprotein IIb/IIIa inhibitors.

    • Main Results:

    • Introduction of stents and atherectomy significantly improved percutaneous coronary intervention (PCI) outcomes.
    • Glycoprotein IIb/IIIa inhibitors reduced procedure-related complications by preventing platelet aggregation.
    • Emerging technologies like distal protection devices, brachytherapy, and drug-eluting stents address restenosis and embolism.

    Conclusions:

    • PCI has evolved substantially, with technological and pharmacological advancements mitigating earlier limitations.
    • Ongoing innovations are poised to expand the therapeutic scope and effectiveness of PCI.
    • Future developments hold promise for further improving patient outcomes in coronary artery disease management.